Evolent Health Acquires IPG from TPG Growth for $375M

June 29, 2022

Evolent Health agreed to acquire IPG, a provider of surgical cost management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus up to $87 million of contingent consideration. The IPG platform will be integrated into Evolent’s New Century Health business to expand the company's value-based specialty care capabilities and add new payer and ambulatory surgery center relationships; the deal is expected to be immediately accretive to adjusted EBITDA.

Buyers
Evolent Health, Inc.
Targets
IPG
Sellers
TPG Growth
Location
Georgia, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.